Nandish Vyas
Senior Partner
MumbaiPractice Area
Sectors
I enjoy the process of working on transactions, translating commercial requirements into a legal framework and adopting a resolution–based approach to negotiations. I am passionate about legal research and find joy in training younger colleagues.
Nandish Vyas is an experienced corporate lawyer with considerable experience in corporate acquisitions and private equity investments.
Chambers & Partners Asia–Pacific (2026)Nandish Vyas has close to two decades of experience in corporate, private equity acquisitions, mergers, and restructuring transactions. He has assisted regulators in framing rules for corporate and competition laws and is recognised for his work by leading publications and journals. Prior to focusing on corporate transactions, he was a Research Assistant for India’s leading income–tax commentary and a commercial litigation lawyer.
DIRECTORSHIPS, MEMBERSHIPS AND AFFILIATIONS
- Invitee, Ministry of Corporate Affairs for drafting of rules relating to Merger & Amalgamations under the Companies Act, 2013 (2016)
- Invitee, Ministry of Corporate Affairs for drafting of rules relating to Merger Control under the Competition Act, 2002 (2011)
WORK HIGHLIGHTS
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
-
In connection with a significant investment in the Jubilant Bhartia Group for their acquisition of a 40% stake in Coca-Cola’s India bottler (Hindustan Coca-Cola Beverages) for approximately USD 1.5 billion.
-
On the divestment of a 90% stake in HDFC Credila to BPEA EQT and ChyrsCapital for approximately USD 1.3 billion.
-
On the acquisition of Medicover India, a pan-India multi-specialty healthcare provider, for USD 1.4 billion.
-
In connection with its USD 900 million investment in Cred (Dreamplug Technologies Private Limited).
-
For its USD 2.2 billion AI data centre joint venture with TPG.
-
Advised the seller trusts owning Vitabiotics (Meyer Organics) on the sale to Bain for USD 1.2 billion.
RECENT RECOGNITION
2026
2025
2024
2023
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Resight India
Ranked at #7, amongst 50 Lawyers for RSGI Private Capital Rankings
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Resight India
Ranked at #6, amongst 50 Lawyers for RSGI Private Capital Rankings
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Legal Era
Named a Leading Lawyer for Private Equity
RECENT RECOGNITION
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Resight India
Ranked at #7, amongst 50 Lawyers for RSGI Private Capital Rankings
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Resight India
Ranked at #6, amongst 50 Lawyers for RSGI Private Capital Rankings
Asialaw Profiles
‘Distinguished Practitioner’ for Corporate/ M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A and Private Equity
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Asialaw Profiles
‘Notable Practitioner’ for Corporate/M&A and Private Equity
Chambers & Partners Asia–Pacific
Ranked for Corporate/M&A and Private Equity
Chambers & Partners Global
Ranked for Corporate/M&A
IFLR1000
‘Notable Practitioner’ for M&A
Legal 500 Asia Pacific
Recommended for Corporate/M&A
Legal Era
Named a Leading Lawyer for Private Equity